menu close
www.synthego.com
Synthego Corporation-Logo

Synthego Corp Stock

Company Profile:

Synthego is a leading provider of genome engineering solutions. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.

Sign up for SecondMarket™ to view the market and buy or sell Synthego Corp Stock
Buy + Sell

Synthego Corp Funding

Sign up to gain insights into Synthego Corp funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Dec 31, 2021 Series E 135.00M
Price
Valuation
Jun 11, 2020 Series D 100.00M
Price
Valuation
Oct 09, 2018 Series C 106.27M
Price
Valuation
Dec 21, 2016 Series B 40.70M
Price
Valuation
Jun 26, 2013 Series A 8.29M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Synthego Corp Management Team

  • Chief Innovation Officer

    Fabian Gerlinghaus

  • Chief Operating Officer

    John Tan

  • Chief Scientific Officer

    Robert Deans

  • Director

    Drew Oetting

  • CEO, Director

    Paul Dabrowski

  • President, Director

    Michael Dabrowski

  • Director

    Scott Nolan

Synthego Corp Major Investors

  • Perceptive Advisors, LLC

  • Laurion Capital Management

  • Chimera Partners Ltd

  • Perceptive Advisors, LLC

  • Logos Capital

  • Moore Strategic Ventures

  • RA Capital Management LLC

  • WI Harper Group Inc

  • Declaration Partners

  • Intel Capital Corp

  • 8VC

  • Softbank Vision Fund 2

  • The Founders Fund

  • Menlo Ventures

  • Gigafund

  • Wellington Management Company LLP

Learn More About Synthego Corp Stock

Buy Synthego Corp Stock
01

Synthego Corp stock does not trade on public stock exchanges. Synthego Corp stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Synthego Corp stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Synthego Corp Stock
02

Synthego Corp Stock does not trade on public stock exchanges. In order to sell Synthego Corp shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Synthego Corp Stock Price
03

Synthego Corp does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Synthego Corp share price and other valuable private market data.

Read more about secondary market private company stock prices:

Synthego Corp Stock Ticker Symbol
04

There is no ticker symbol for Synthego Corp stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Synthego Corp Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Synthego Corp stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Synthego Corp Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Synthego Corp stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Synthego Corp Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Synthego Corp IPO
08

Synthego Corp is a private company and has not had an IPO. There is currently no Synthego Corp IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Synthego Corp IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Synthego Corp Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Orcabio-Logo

Orca Bio

A clinical-stage biotechnology company developing a pipeline of high-precision allogeneic cell therapy products.

Upsidefoods-Logo

UPSIDE Foods

Produces environmentally friendly meat from animal cells.

Mammothbio-Logo

Mammoth Biosciences

Developed a CRISPR-based platform for disease detection using Cas12 and Cas13 proteins, to enable the detection of any type of nucleic acid.

Source: Nasdaq Private Market Tape D™